Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mel B Feany

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
The American Journal of Pathology|April 6, 2010
ASIP Outstanding Investigator Award Lecture. New approaches to the pathology and genetics of neurodegenerationMel B Feany
The New England Journal of Medicine|November 5, 2004
New genetic insights into Parkinson's diseaseMel B Feany
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 2, 2021
Precision Medicine on the Fly: Using Drosophila to Decipher Gene-Environment Interactions in Parkinson's DiseaseSouvarish Sarkar, Mel B Feany
Nature Neuroscience|April 19, 2005
Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson diseaseLi Chen, Mel B Feany
Surgical Pathology Clinics|May 12, 2020
Iatrogenic Neuropathology of Systemic TherapiesMatthew Torre, Mel B Feany
Biochimica Et Biophysica Acta|December 5, 2006
Connecting cell-cycle activation to neurodegeneration in DrosophilaVikram Khurana, Mel B Feany
Human Molecular Genetics|July 16, 2004
Comparison of pathways controlling toxicity in the eye and brain in Drosophila models of human neurodegenerative diseasesSrimoyee Ghosh, Mel B Feany
Glia|July 4, 2019
Glial α-synuclein promotes neurodegeneration characterized by a distinct transcriptional program in vivoAbby L Olsen, Mel B Feany
Genetics|December 12, 2003
Genetic modifiers of tauopathy in DrosophilaJoshua M Shulman, Mel B Feany
The New England Journal of Medicine|January 31, 2019
PARP Inhibitors and Parkinson's DiseaseAbby L Olsen, Mel B Feany
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
The American Journal of Pathology|April 6, 2010
ASIP Outstanding Investigator Award Lecture. New approaches to the pathology and genetics of neurodegenerationMel B Feany
The New England Journal of Medicine|November 5, 2004
New genetic insights into Parkinson's diseaseMel B Feany
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 2, 2021
Precision Medicine on the Fly: Using Drosophila to Decipher Gene-Environment Interactions in Parkinson's DiseaseSouvarish Sarkar, Mel B Feany
Nature Neuroscience|April 19, 2005
Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson diseaseLi Chen, Mel B Feany
Surgical Pathology Clinics|May 12, 2020
Iatrogenic Neuropathology of Systemic TherapiesMatthew Torre, Mel B Feany
Biochimica Et Biophysica Acta|December 5, 2006
Connecting cell-cycle activation to neurodegeneration in DrosophilaVikram Khurana, Mel B Feany
Human Molecular Genetics|July 16, 2004
Comparison of pathways controlling toxicity in the eye and brain in Drosophila models of human neurodegenerative diseasesSrimoyee Ghosh, Mel B Feany
Glia|July 4, 2019
Glial α-synuclein promotes neurodegeneration characterized by a distinct transcriptional program in vivoAbby L Olsen, Mel B Feany
Genetics|December 12, 2003
Genetic modifiers of tauopathy in DrosophilaJoshua M Shulman, Mel B Feany
The New England Journal of Medicine|January 31, 2019
PARP Inhibitors and Parkinson's DiseaseAbby L Olsen, Mel B Feany
Pageof 10